Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

H1N1 Influenza A Vaccine (Split Virion)，Inactivated

Approval Number

国药准字S20090016

Company华兰生物疫苗股份有限公司

Registration Date

July 9, 2020

Previous Approval Numbers

国药准字S20090016

Drug Information

Generic Name

甲型H1N1流感病毒裂解疫苗

Dosage Form

注射剂

Strength

15μg/0.5ml/支。每一次人用剂量0.5ml,含甲型H1N1流感病毒血凝素抗原15μg。

Drug Type

生物制品

Registration Date

July 9, 2020

Company Information

Applicant Company

Company Name华兰生物疫苗股份有限公司

Manufacturing Company

Company Name华兰生物疫苗股份有限公司

Company Address

河南省新乡市华兰大道甲1号附1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy